Drug · DIN 02408899
MINT-GABAPENTIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 25, 2023; first marketed August 25, 2023.
- Drug Identification Number (DIN)
- 02408899
- Company (DIN owner)
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Gabapentin N02BF01
- Class
- Human
- Record last updated
- January 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GABAPENTIN | 300 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 17, 2013: NOC 14553Abbreviated New Drug Submission (ANDS)
Other DINs named MINT-GABAPENTIN
- DIN 02408880 · Marketed
- DIN 02408902 · Marketed